Clinical Efficacy of Adaptive Therapy for Acute Posterior Circulation Cerebral Infarction After Remote Ischemia

ZHAO Xia

doi:10.14033/j.cnki.cfmr.2025.19.009

Abstract：Objective:To explore the clinical efficacy of Remote Ischemic Post adaptation(RIPostC)in the treatment of acute posterior circulation cerebral infarction(APCI).Method:100 APCI patients admitted to Xinhua Hospital of Ili Kazakh Autonomous Prefecture from May 2023 to April 2024 were randomly divided into experimental group(n=50)and control group(n=50).The control group received conventional treatment,while the experimental group received conventional treatment plus RIPostC treatment for 2 weeks.The modified Ranlin Scale(mRS)scores,Barthel Index(BI)scores,Extended National Institutes of Health Stroke Scale(e-NIHSS)scores,and incidence of adverse reactions during treatment in two groups before and after 2,4,and 12 weeks of treatment were observed.Result:The total effective rate of the experimental group was higher than that of the control group,and the difference was statistically significant(P<0.05).There were statistically significant differences in the time factors,inter group factors,and time and inter group interactions of e-NIHSS,BI,and mRS scores between the two groups(P<0.05).After treatment,the BI scores of the experimental group were higher than those of the control group at all time points,while the e-NIHSS and mRS scores were lower than those of the control group,and the differences were statistically significant(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:RIPostC treatment for APCI patients can significantly improve clinical outcomes,neurological function,and daily living abilities.It has good safety.